These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29195774)

  • 1. Paving TRAIL's Path with Ubiquitin.
    Lafont E; Hartwig T; Walczak H
    Trends Biochem Sci; 2018 Jan; 43(1):44-60. PubMed ID: 29195774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progress on targeting TRAIL's receptor as antitumor strategy].
    Chen SZ
    Yao Xue Xue Bao; 2009 Dec; 44(12):1336-42. PubMed ID: 21351465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The linear ubiquitin chain assembly complex regulates TRAIL-induced gene activation and cell death.
    Lafont E; Kantari-Mimoun C; Draber P; De Miguel D; Hartwig T; Reichert M; Kupka S; Shimizu Y; Taraborrelli L; Spit M; Sprick MR; Walczak H
    EMBO J; 2017 May; 36(9):1147-1166. PubMed ID: 28258062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
    Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
    Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences and Similarities in TRAIL- and Tumor Necrosis Factor-Mediated Necroptotic Signaling in Cancer Cells.
    Sosna J; Philipp S; Fuchslocher Chico J; Saggau C; Fritsch J; Föll A; Plenge J; Arenz C; Pinkert T; Kalthoff H; Trauzold A; Schmitz I; Schütze S; Adam D
    Mol Cell Biol; 2016 Oct; 36(20):2626-44. PubMed ID: 27528614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoprotegerin (OPG) binds with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): suppression of TRAIL-induced apoptosis in ameloblastomas.
    Sandra F; Hendarmin L; Nakamura S
    Oral Oncol; 2006 Apr; 42(4):415-20. PubMed ID: 16413220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of ubiquitination in extrinsic cell death pathways and its implications for therapeutics.
    Seo J; Kim MW; Bae KH; Lee SC; Song J; Lee EW
    Biochem Pharmacol; 2019 Apr; 162():21-40. PubMed ID: 30452908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperative TRAIL production mediates IFNα/Smac mimetic-induced cell death in TNFα-resistant solid cancer cells.
    Roesler S; Eckhardt I; Wolf S; Fulda S
    Oncotarget; 2016 Jan; 7(4):3709-25. PubMed ID: 26788912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-related apoptosis-inducing ligand: signalling of a 'smart' molecule.
    Manzo F; Nebbioso A; Miceli M; Conte M; De Bellis F; Carafa V; Franci G; Tambaro FP; Altucci L
    Int J Biochem Cell Biol; 2009 Mar; 41(3):460-6. PubMed ID: 18243765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The three Rs along the TRAIL: resistance, re-sensitization and reactive oxygen species (ROS).
    Mellier G; Pervaiz S
    Free Radic Res; 2012 Aug; 46(8):996-1003. PubMed ID: 22559302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) pathway signaling.
    Thorburn A
    J Thorac Oncol; 2007 Jun; 2(6):461-5. PubMed ID: 17545839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traditional Chinese medicines and their active ingredients sensitize cancer cells to TRAIL-induced apoptosis.
    Sun B; Liu Y; He D; Li J; Wang J; Wen W; Hong M
    J Zhejiang Univ Sci B; 2021 Mar; 22(3):190-203. PubMed ID: 33719224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wogonin enhances antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo through ROS-mediated downregulation of cFLIPL and IAP proteins.
    Yang L; Wang Q; Li D; Zhou Y; Zheng X; Sun H; Yan J; Zhang L; Lin Y; Wang X
    Apoptosis; 2013 May; 18(5):618-26. PubMed ID: 23371323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Playing the DISC: turning on TRAIL death receptor-mediated apoptosis in cancer.
    Pennarun B; Meijer A; de Vries EG; Kleibeuker JH; Kruyt F; de Jong S
    Biochim Biophys Acta; 2010 Apr; 1805(2):123-40. PubMed ID: 19961901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Following TRAIL's path in the immune system.
    Falschlehner C; Schaefer U; Walczak H
    Immunology; 2009 Jun; 127(2):145-54. PubMed ID: 19476510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAIL as a target in anti-cancer therapy.
    Wu GS
    Cancer Lett; 2009 Nov; 285(1):1-5. PubMed ID: 19299078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAIL signalling: decisions between life and death.
    Falschlehner C; Emmerich CH; Gerlach B; Walczak H
    Int J Biochem Cell Biol; 2007; 39(7-8):1462-75. PubMed ID: 17403612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marine Drugs Regulating Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL).
    Elmallah MI; Micheau O
    Mar Drugs; 2015 Nov; 13(11):6884-909. PubMed ID: 26580630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From biochemical principles of apoptosis induction by TRAIL to application in tumour therapy.
    Cordier SM; Papenfuss K; Walczak H
    Results Probl Cell Differ; 2009; 49():115-43. PubMed ID: 19142621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells.
    Shi RX; Ong CN; Shen HM
    Cancer Res; 2005 Sep; 65(17):7815-23. PubMed ID: 16140950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.